Andrew R. Allen - 24 Jun 2024 Form 4 Insider Report for Gritstone bio, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Jun 2024, 21:25:58 UTC
Prior SEC filing
17 May 2024
Next SEC filing
01 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Vassiliki Economides, Attorney-in-Fact for Andrew R. Allen

Key filing fact

Andrew R. Allen filed Form 4 for Gritstone bio, Inc. on 26 Jun 2024.

Key facts

  • This page summarizes Andrew R. Allen's Form 4 filing for Gritstone bio, Inc..
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Jun 2024, 21:25.

Change

  • Previous filing in this sequence was filed on 17 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GRTS transaction

Common Stock

Gift

Transaction value
$0
Shares
-325,000
Change %
-22%
Price
$0.000000
Shares after
1,124,275
Date
24 Jun 2024
Ownership
See footnote
Footnotes
F1, F2
GRTS transaction

Common Stock

Gift

Transaction value
$0
Shares
-325,000
Change %
-25%
Price
$0.000000
Shares after
985,360
Date
24 Jun 2024
Ownership
Direct
Footnotes
F3
GRTS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
325,000
Date
24 Jun 2024
Ownership
Allen 2024 Gift Trust
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The reported transaction represents a bona fide gift for no consideration of the following shares of the issuer's Common Stock to the direct beneficial ownership of the reporting person: (i) 162,649 shares from the Allen 2022 Annuity Trust and (ii) 162,351 shares from The Allen Revocable Trust dated 12/19/2013.

Footnote F2

The shares are directly held by the Allen 2022 Annuity Trust and The Allen Revocable Trust dated 12/19/2013 (collectively, the "Trusts") for which the reporting person serves as a co-trustee. The reporting person disclaims beneficial ownership of the shares held by the Trusts except to the extent of his pecuniary interest therein.

Footnote F3

The reported transaction represents a bona fide gift for no consideration of 325,000 shares of the issuer's Common Stock to from the direct beneficial ownership of the reporting person to the Allen 2024 Gift Trust, a revocable trust for which the reporting person serves as a co-trustee.

Footnote F4

The shares are directly held by the Allen 2024 Gift Trust (the "2024 Trust"), a revocable trust for which the reporting person serves as a co-trustee. The reporting person disclaims beneficial ownership of the shares held by the 2024 Trust except to the extent of his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .